Source link : https://asia-news.biz/asia/asia-pacific-roundup-drap-advises-firms-in-pakistan-on-preventing-deg-eg-contamination-regulatory-affairs-professionals-society-raps/
Asia-Pacific Roundup: DRAP Advises Firms in Pakistan on Preventing DEG and EG Contamination
In a proactive move to safeguard public health, the Drug Regulatory authority of Pakistan (DRAP) has issued new guidance aimed at pharmaceutical manufacturers in the country, focusing on the critical prevention of contamination by harmful compounds diethylene glycol (DEG) and ethylene glycol (EG). The advisory comes in the wake of several high-profile cases where these toxic substances inadvertently found their way into products, raising notable safety concerns and prompting calls for stricter regulatory measures. This advancement underscores the urgency for Pakistan’s pharmaceutical industry to enhance quality control practices and adhere to established safety protocols. In this installment of the Asia-pacific Roundup,we delve into the specifics of DRAP’s guidance,its implications for industry compliance,and the broader context of regulatory efforts across the region.
Asia-Pacific Regulatory Landscape: DRAP Issues Guidance on DEG and EG Contamination Prevention
The Drug Regulatory Authority of Pakistan (DRAP) has recently issued significant guidance aimed at pharmaceutical firms to bolster the prevention of diethylene glycol (DEG) and ethylene glycol (EG) contamination in medicinal products.These compounds, which are toxic and harmful to…
—-
Author : Miles Cooper
Publish date : 2025-04-29 04:14:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8